Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2023-02-09 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
章程修订对照表
Governance Information Classification · 95% confidence The document is a comparison table showing amendments to the company's articles of association (章程修订对照表), specifically changes in registered capital and share capital details. It does not contain financial statements, audit information, or meeting results. It is a governance-related document detailing internal company rules and capital structure changes reflected in the articles. Therefore, it fits best under Governance Information (CGR). The document length is short but contains substantive content about governance changes, not just an announcement or notice.
2023-02-09 Chinese
重药控股股份有限公司公司章程（2023年2月）
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association (章程) for 重药控股股份有限公司, covering company governance, shareholder rights, board structure, share issuance, and meeting procedures. It includes extensive provisions on shareholder meetings, board and management roles, share issuance and repurchase, and other corporate governance matters. It is not a financial report, earnings release, or announcement but a governance document outlining the internal rules and structure of the company. Therefore, it fits the category of Governance Information (CGR). The document length and content confirm it is the full governance charter, not a brief announcement or summary.
2023-02-09 Chinese
关于聘任公司副总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new deputy general manager (vice president) of the company. It includes details about the appointment decision, the individual's resume, and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, reports, or shareholder votes. This fits the category of Board/Management Information, which covers announcements of changes in senior management.
2023-02-09 Chinese
关于终止实施2020年限制性股票激励计划暨回购注销已授予但尚未解除限售的限制性股票的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from a company regarding the termination of its 2020 restricted stock incentive plan and the repurchase and cancellation of restricted shares that have been granted but not yet released from sale restrictions. It details the approval process, reasons for termination, repurchase price, quantity, and legal opinions. The document is a formal announcement about a capital change event related to stock repurchase and cancellation, not a full financial report or audit. It does not contain financial statements or detailed financial analysis but focuses on corporate actions affecting share capital. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is 4200 characters, which is consistent with an announcement rather than a full report.
2023-02-09 Chinese
关于副总经理辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's Vice General Manager. It includes details about the resignation, the effective date, and the shareholding of the resigning executive. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no indication of a report or presentation. This fits the category of Board/Management Information, which covers announcements of changes in senior management.
2023-02-03 Chinese
关于控股子公司2023年度第一期超短期融资券发行结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行结果公告" which translates to "Issuance Result Announcement" for a short-term financing bond issued by a subsidiary. It provides details about the issuance amount, interest rate, dates, and registration information. The document is short (1242 characters) and focuses on announcing the results of a financing activity rather than providing a full financial report or detailed analysis. This fits the definition of a Capital/Financing Update (CAP) as it updates on company fundraising and financing activities. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a regulatory filing or announcement of a report publication. Therefore, the correct classification is CAP with high confidence.
2023-01-16 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.